Lafutidine
Lafutidine is a novel histamine H2 receptor antagonist developed for research, primarily used to inhibit gastric acid secretion. It is applied in pharmacological studies of gastrointestinal disorders, utilizing both in vitro receptor binding assays and in vivo models of gastric acid secretion.
Product Specifications
CAS Number
118288-08-7
Product Name Alternative
Disease, colonic, antiulcer, antisecretory, 5HTReceptor, 5HT Receptor, HT, FRG 8813, FRG8813, FRG-8813, gastric, gastroesophageal, Inhibitor, HistamineReceptor, Histamine Receptor, histamine, Lafutidine, inhibit, mucosal, mucus, protective, reflux, receptor, secretion
Field of Research
Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Purity
98.55% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.5 mg/mL (5.79 mM) ; Ethanol:11 mg/mL (25.49 mM) ; DMSO:80 mg/mL (185.38 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
O=C (CS (=O) CC1=CC=CO1) NC\C=C/COC1=NC=CC (CN2CCCCC2) =C1
Molecular Formula
C22H29N3O4S
Molecular Weight
431.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog